Moonshots with Peter Diamandis

Podbit · Moonshots with Peter Diamandis

Michael Kratsios on the New Golden Age of American Science | EP #276

Explore episode Aug 4, 2026
Science
The 2x Goal Was Too Conservative — We Should Be Aiming for 10x

Michael Kratsios on the New Golden Age of American Science … · Aug 4, 2026 Science

The Genesis Mission's stated goal of doubling scientific productivity was set before the AI explosion of the last six months. On air, Kratsios admits the number should probably be 10x — and that Anthropic's revenue going from $10 billion to over $70 billion in seven months shows exactly why the original target is already outdated.

Where this was said

Autonomous Labs: Closed-Loop Science at Machine Speed

At 1:04:22 · chapter starts 1:03:30

Peter and Kratsios discuss the autonomous self-driving lab concept — a fully closed-loop scientific system where AI proposes hypotheses, robotic platforms run experiments continuously, and models immediately read results and design follow-up experiments without human intervention. Lila Sciences is cited as a real-world example, reportedly building out a million square feet of autonomous lab space. Kratsios wants federal funding to test experiments on these platforms, acknowledging that the near-term bottleneck is hardware capable of running a sufficiently broad range of experiment types. He believes universities will be early movers — they have strong incentives to offer the most powerful tools to their scientists. Peter adds the democratizing dimension: these platforms could eventually give a high school student access to national lab equipment, collapsing the institutional gatekeeping that currently controls who gets to run experiments.

Similar podbits

Science
The Placebo Effect Is Not Fake — It Just Belongs to the Story, Not the Drug

#403 ‒ Peptides: separating scientific promise from marketi… · Aug 10, 2026 Science

Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.